Immunopathogenesis of human immunodeficiency virus

Seminars in Nephrology

Volumn 18, Issue 4, 1998, Pages 422-435

  Ahsan, Nasimul ^a   Langhoff, Erik ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; VIRUS RECEPTOR;

APOPTOSIS; AUTOIMMUNITY; CELL SPECIFICITY; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS LATENCY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; APOPTOSIS; AUTOIMMUNITY; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; LYMPHOCYTE COUNT; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 0031855322     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (132)

1. Chun T-W, Carruth L, Finzi D, et al: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-187, 1997
2. Perelson AS, Essunger P, Cao Y, et al: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191, 1997
3. Pantaleo G, Graziosi C, Fauci AS: The immunopathogenesis of human immunodeficiency virus infection. N Eng J Med 328:327-335, 1993
4. Tindall B, Cooper DA: Primary HIV infection: Host responses and intervention strategies. AIDS 5:1-14, 1990
5. Clark SJ, Saag MS, Decker WD, et al: High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 324:954-960, 1991
6. Daar ES, Mudgil T, Meyer RD, Ho DD: Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324:961-964, 1991
7. Buchbinder SP, Katz MH, Hessol NA, et al: Long term HIV-infection without immunologie progression. AIDS 8:1123-1128, 1994
8. Michael NL, Vahey M, Burke DS, Redfield RR: Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: Evidence of viral replication in all stages of HIV disease. J Virol 66:310-316, 1992
9. Lifson AR, Buchbinder SP, Sheppard HW: Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexsual men with normal CD4+ lymphocyte counts: Immunology and virologie characteristics. J Infect Dis 163:959-965, 1991
10. Koup RA, Safrit JT, Cao Y, et al: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650-4655, 1994
11. Walker BD, Plata F: Cytotoxic T lymphocytes against HIV. AIDS 4:177-184, 1990
12. Albert J, Abrahamsson B, Nagy K, et al: Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 4:107-112, 1990
13. Kohler H, Goudsmit J, Nara P: Clonal dominance: Cause for a limited and failing immune response to HIV-1 infection and vaccination. AIDS 5:1158-1168, 1992
14. Moore JP, Cao Y, Ho DD, Koup RA: Development of the anti-gp!20 antibody responses during seroconversion to human immunodeficiency virus type 1. J Virol 68:51425155, 1994
15. Miedema F, Meyaard L, Koot M, et al: Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 140:35-72, 1994
16. McMichael AJ, Gotch FM, Noble GR, Beare PA: Cytotoxic T-cell immunity to influenza. N Engl J Med 309:1317, 1983
17. McMichael AJ, Walker BD: Cytotoxic T lymphocyte epitopes: Implications for HIV vaccines. AIDS 8:155-160, 1994
18. Walker BD, Chakrabarti S, Moss B, et al: HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328:345-348, 1987
19. Klein M. Baalen C, Holwerda A, et al: Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: A longitudinal analysis of rapid progressors and longterm asymptomatics. J Exp Med 181:1365-1372, 1995
20. Safrit J, Andrews C, Zhu C, et al: Characterization of human immunodeficiency virus type 1 specific cytotoxic T lymphocyte clones isolated during acute seroconversion: Recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Immunol 179:463, 1994
21. Borrow P, Lewicki H, Hahn B, et al: Virus-specific CD8+ cytotoxic T-Iymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103, 1994
22. Culman B, Gomard E, Mieny MP, et al: Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 nef protein. J Immunol 146:1560-1565, 1991
23. Johnson RP, Trocha A, Yang L, et al: HIV-1 gagspecific cytotoxic T lymphocytes recognized multiple highly conserved epitopes. J Immunol 147:1512-1521, 1991
24. Haas G, Plikat U, Debre P, et al: Dynamics of viral variants in HIV-1 nef and specific cytotoxic T lymphocytes in vivo. J Immunol 157:4212-4221, 1996
25. Koenig S, Fuerst TR, Wood LV, et al: Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. J Immunol 145:127-135, 1990
26. Carmichael A, Jin X, Sissons P, Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HlV-l)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 177:249-256, 1993
27. Klein G: Viral latency and tranformation: The strategy of Epstein-Barr virus. Cell 58:5-8, 1989
28. van Baalen CA, Klein MR, Huisman RC, et al: Finespecificity of cytotoxic T lymphocytes which recognize conserved epitopes of the gag protein of human immunodeficiency virus type 1. J Gen Virol 77:1659-1665, 1996
29. Lucchiari-Hartz M, Bauer M, Niedermann G, et al: Human immune response to HIV-1 nef. II. Induction of HIVl/HIV-2 nef cross-reactive cytotoxic T lymphocytes in peripheral blood lymphocytes of non-infected healthy individuals. Intl Immunol 8:577-584, 1996
30. Harrer T, Harrer E, Kalams SA, et al: Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J Immunol 156:2616-2623, 1996
31. Buseyne F, McChesney M, Porrot F, et al: Gag-specific cytotoxic T lymphocytes form human immunodeficiency virus type 1-infected individual. Gag epiotopes are clustered in three regions of the p24gag protein. J Immunol 67:694702, 1993
32. Cunmann-Penciolelli B, Lamhamedi-Cherradi S, Couillin I, et al: Identification of multi-restricted immunodominant regions recognized by cytolytic T lymphocytes in the human immunodeficiency virus type 1 nef protein. J Virol 68:7336, 1994
33. Klotman ME, Kim S, Buchbinder A, et al: Kinetics of expression of multiple spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. J Virol 67:6365, 1991
34. Cocchi F, DeVico AL, Garzino-Demo A, et al: Identification of RANTES, MIP-lalfa, MIP-lbeta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815, 1995
35. Baier M, Werner A, Bannen N, et al: HIV suppression by interleukin-16. Nature 378:563, 1995
36. Pantaleo G, Demarest JF, Soudeyns H, et al: Major expansion of CD+ T cells with predominant V usage during the primary immune response to HIV. Nature 370:463-467, 1994
37. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011-1018, 1993
38. Sheppard HW, Ascher MS, McRae B, et al: The initial immune response to HIV and the immune system activation determine the outcome of HIV disease. J AIDS 4:701-712, 1991
39. Graziosi C, Gantt KR, Vaccareza M, et al: Kinetics of cytokine expression during primary Human Immunodeficiency Virus type 1 infection. Proc Natl Acad Sei USA 93:4386-4391, 1996
40. Meyaard L, Schuitemaker H, Miedema F: T-cell dysfunction in HIV infection: Anergy due to defective antigenpresenting cell function? Immunol Today 14:161-164, 1993
41. Clerici M, Shearer GM: A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107-111, 1993
42. Graziosi G, Pantaleo G, Gantt KR, et al: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265:248-252, 1994
43. Cao Y, Qin L, Zhang L, et al: Virologie and immunologie characterization of long-term survivors of human immunodeficiency virus type I infection. N Engl J Med 332:210, 1995
44. Pantaleo G, Menzo S, Vaccarezza M, et al: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209, 1995
45. Greenough TC, Somasundaran M, Brettler DB, et al: Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 10:395-403, 1994
46. Keet IP, Krol A, Klein MR, et al: Characteristics of long term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J Infect Dis 169:1236-1243, 1994
47. Levy JA: Features of human immunodeficiency virus infection and disease. Pediatr Res 33:63-69, 1993
48. Pantaleo G, Fauci AS: Immunopathogenesis of HIV infection. Ann Rev Microbiol 50:825-854, 1996
49. Kirchhoff F, Greenough TC, Brettler DB, et al: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 332:228-232, 1995
50. Delwart EL, Sheppard HW, Walker BD, et al: Human Immunodeficiency Virus type l evolution in vivo tracked by DNA heteroduplex mobility assays. J Virol 68:6672-6683, 1994
51. Huang Y, Zhang L, Ho DD: Characterization of nef sequences in long-term survivors of Human Immunodeficiency Virus type 1 infection. J Virol 69:93-100, 1995
52. Deacon NJ, Tsykin A, Solomon S, et al: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipient. Science 270:988-991, 1995
53. Liu R, Paxton WA, Choe S, et al: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 86:367-377, 1996
54. Smith MW, Dean M, Carrington M, et al: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-965, 1997
55. Pincus SH, Messer KG, Nara PL, et al: Temporal analysis of the antibody response to HIV envelope protein in HIV infected laboratory workers. J Clin Invest 93:2505-2513, 1994
56. Munoz A, Vlahov D, Solomon L, et al: Prognostic indicators for development of AIDS among intravenous drug users. J AIDS 5:694-700, 1992
57. Tersmette M, de Goede RE, Al BJ, et al: Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent dectection of sycytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62:2026-2032, 1988
58. Pantaleo G, Graziosi G, Demarest JF, et al: Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infecion. Immunol Rev 140:105-130, 1994
59. Reiman KA, Tenner-Racz K, Racz P: Immunopathogenic events in acute infection of Rhesus monkeys with Simian immunodeficiency virus of macaques. J Virol 68:23622370, 1994
60. Chakrabarti L, Isola P, Cumomt M, et al: Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol 144:1226-1237, 1994
61. Pantaleo G, Craziosi C, Demarest JF, et al: HIV infection is active and progressive in lymphoid tissue during the clinical latent stage of disease. Nature 362:355-358, 1993
62. Embretson J, Zupancic M, Ribas JL, et al: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359-362, 1993
63. Pantaleo G, Fauci AS: New concept in the immunopathogenesis of HIV infection. Annu Rev Immunol 13:487-512, 1995
64. Levy JA: HIV pathogenesis and long-term survival. AIDS 7:1401-1410, 1993
65. Armstrong JA, Home R: Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet ii:370-372, 1984
66. Mosialos G, Birkenbach M, Ayehunie S, et al: Circulating human dendritic cells differentially express high levels of a p55-kD actin-bundling protein. Am J Pathol 148:593-600, 1996
67. Frankel SS, Wenig BM, Burke AP, et al: Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272:115-117, 1966
68. Langhoff E, Kalland K-H, Haseltine WA: Early molecular replication of Human Immunodeficiency Virus Type 1 in cultured blood-derived T helper dendritic cells. J Clin Invest 91:2721-2726, 1993
69. Langhoff E, Haseltine WA: A possible role of dendritic cells in HIV-1 replication and transmission, vol. 3. New York, NY, Marcel Dekker, 1993
70. Ayehunie S, Bruzzese A-M, Groves RW, Kupper TS: HIV-1 transmission by mucosal Langerhans cells, blood dendritic cells, and monocytes in vitro. Regional Immunol 6:105-111, 1994
71. Ayehunie S, Groves RW, Bruzzese A-M, et al: Acutely infected Langerhans cells are more efficient than T cells in dissiminating HIV Type 1 to activated T cells following a short cell-to-cell contact. AIDS Res Hum Retroviruses 11:877-884, 1995
72. Cameron PU, Pope M, Gezelter S, Steinman RM: Infection and apoptotic cell death of CD4+ T cells during an immune response to HIV-1-pulsed dendritic cells. AIDS Res Hum Retroviruses 10:61-71, 1994
73. Cameron PU, Lowe MG, Crowe SM, et al: Susceptibility of dendritic cells to HIV-1 infection in vitro. J Leuk Biol 56:257-265, 1994
74. Dusserre N, Dezutter-Dambuyant C, Mallet F, et al: In vitro HIV-1 entry and replication in Langerhans cells may clarify the HIV-1 genome detection by PCR in epidermis of seropositive patients. J Invest Derm 99:99S-102S, 1992
75. Zambruno G, Giannetti A, Bertazzoni U, Girolomoni G: Langerhans cells and HIV infection. Immunol Today 16:250-254, 1995
76. Willey RL, Theodore TS, Martin MA: Aminoacid substitutions in the Human Immunodeficiency Virus type 1 gp!20 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J Virol 68:4409-4419, 1994
77. Feng-Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-877, 1996
78. Deng H, Liu R, Ellmeier W, et al: Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666, 1996
79. Dragic T, Litwin V, AHaway GP, et al: HIV-1 entry into CD4+ cells is mediated by the chemokine receptore CCCKR-5. Nature 381:667-673, 1996
80. Choe H, Farzan M, Suln Y, et al: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148, 1996
81. Doranz BJ, Rucker J, Yanjie Y, et al: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CXR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158, 1996
82. Samson M, Libert F, Doranz BJ, et al: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722725, 1996
83. Gary RF: Potential mechanisms for the cytopathic properties of HIV. AIDS 3:683-694, 1989
84. Lifson JD: Fusion of Human Immunodeficiency Virusinfected cells with uninfected cells. Meth Enzymol 221:3-12, 1993
85. Hildreth JEK, Orentas RJ: Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244:1075-1078, 1989
86. Pantaleo G, Butini L, Graziosi C: Human Immunodeficiency Virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIVmediated cell fusion but not for viral transmission. J Exp Med 173:11-18, 1991
87. Butini L, DeFougerolles AR, Vaccarezza M: Intercellular adhesion molecules (ICAM)-l, ICAM-2 and ICAM-3 function as counter-receptors for lymphocyte function-associated molecule-1 in human immunodeficiency virus mediated syncytia formation. Eur J Immunol 24:2191-2199, 1991
88. Katazi F, Chang J, Lopez A, et al: Interleukin 4 and Human Immunodeficiency Virus stimulate LFA-1 ICAM-1mediated aggregation of monocytes and subsequent giant cell formation. J Gen Virol 75:2795-2802, 1994
89. Suga S, Tsurudome M, Ohgimoto S, et al: Identification of fusion regulatory protein (FRP)-1/4F2 related molecules: Cytoskeletal proteins are associated with FRP-1 molecules that regulate multinucleated giant cell formation of monocytes and HIV-induced cell fusion. Cell Struc Func 20:473-483, 1995
90. St Clair MH, Hartigan PM, Andrews JC, et al: Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. AIDS 6:891-897, 1993
91. Zinkernagel RM, Hengartner H: T-cell-mediated immunopathology versus direct cytolysis by virus: Implications for HIV and AIDS. Immunol Today 15:262-268, 1994
92. + repertoire during antiviral therapy. Nature Med 4:215-221, 1998
93. Pakker NG, Notermans DW, De Boer RJ, et al: Diphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation. Nature Med 4:208-214, 1998
94. Acha-Orbea H, Shakhov AN, Scarpellino L, et al: Clonal deletion of V-betal4-bearing T cells in mice transgenic for mammary tumour virus. Nature 350:207-211, 1991
95. Marrack P, Hushnir E, Kappler J: A maternally inherited superantigen encoded by a mammary tumour virus. Nature 349:524-526, 1991
96. Woodland DL, Happ MP, Gollob KJ, Palmer E: An endogenous retrovirus mediating deletion of alfa/beta T cells. Nature 349:529-530, 1991
97. Rammensee H-G, Kroschewski R, Frangoulis B: Clonal anergy induced in mature V-beta6+ T lymphocytes on immunizing Mls-lb mice with Mis-la expressing cells. Nature 339:541-544, 1989
98. Golding H, Robey FA, Gates FT, et al: Identification of homologous regions in Human Immunodeficiency Virus I gp41 and human MHCII beta-1 domain. J Exp Med 167:914923, 1988
99. Golding H, Shearer GM, Hillman K, et al: Common epitope in Human Immunodeficiency Virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV 1infected individuals. J Clin Invest 83:1430-1435, 1989
100. Grassi F, Meneveri R, Gullberg M, et al: Human Immunodeficiency Virus Type 1 gp!20 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J Exp Med 174:53-62, 1991
101. Vega MA, Guigo R, Smith TF: Autoimmune response in AIDS. Nature 345:26, 1990
102. Siliciano RF, Lawton T, Knall C, et al: Analysis of host-virus interactions in AIDS with anti-gp!20 T-cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 54:561-575, 1988
103. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, et al: Unusually high frequences of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 142:452-462, 1989
104. Stricker RB, McHugh TM, Moody DJ, et al: An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature 327:710-713, 1987
105. Huffman G, Kion TA: Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science 253:1138-1140, 1991
106. Habeshaw J, Hounsell E, Dalgleish A: Does the HIV envelope induce a chronic graft-versus-host-Iike disease. Immunol Today 13:207-210, 1992
107. Schwarz A, Offermann G, Keller F, et al: The effect of cyclosporine on the progression of Human Immunodeficiency Virus type 1 infection transmitted by transplantationData on four cases and a review of the literature. Transplantation 55:95-103, 1993
108. Duke RC, Ojcius DM, Young JD-E: Cell suicide in health and disease. Sei Am 275:80-87, 1996
109. Ucker DS, Aswell JD, Nickas G: Activation-driven T cell death: Requirements for de novo transcription and translation and association of genome fragmentation. J Immunol 143:3461-3469, 1989
110. Ju S-T, Panka DJ, Cui H, et al: Fas (CD95)/FasL interactions required for programmed cell death after T cell acitivation. Nature 373:444-448, 1995
111. Brunner T, Mogrill R, LaFace D, et al: Fas (CD95)/ Fas-Ligand interaction mediates activation-induced apoptosis in T-cell hybridoma. Nature 373:441-444, 1995
112. Dhein J, Walczac H, Baumler C, et al: Autocrine Tcell suicide mediated by APO-l/(Fas/CD95). Nature 373:438-441, 1995
113. Cheng J, Zhou T, Liu C, et al: Protection from Fasmediated apoptosis by a soluble form of the Fas molecule. Science 263:1759-1762, 1994
114. Oyaizu N, Pahwa S: Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 15:217-231, 1995
115. Itho N, Tsujimoto Y, Nagata S: Effect of Bcl-2 on Fas antigen mediated cell death. J Immunol 151:621-627, 1993
116. Yoshino T, Kondo E, Cao L, et al: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83:2546-2554, 1994
117. Miyawaki T, Uehara T, Nibu R, et al: Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulation in humn peripheral blood. J Immunol 149:3753-3758, 1992
118. Uehara T, Miyawaki T, Otha K, et al: Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus induced infectious mononucleosis. Blood 80:452-458, 1992
119. Laurent-Crawford AG, Krust B, Muller S, et al: The cytopathic effect of HIV is associated with apoptosis. Virology 185:829-839, 1991
120. Terai C, Kornbluth RS, Pavia D, et al: Apoptosis as a mechnism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 87:1710-1715, 1991
121. Meyaard L, Otto SA, Keet IPM, et al: Programmed death of T cells in Human Immunodeficiency Virus infection. J Clin Invest 93:982-988, 1994
122. Carbonari M, Cibati M, Chercha M, et al: Detection and characterization of apoptotic peripheral blood lymphocytes in Human Immunodeficiency Virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 83:1268-1277, 1994
123. Oyaizu N, McCloskey TW, Corenesi M, et al: Accelerated apoptosis in peripheral blood mononuclear cells (PBMC) from Human Immunodeficiency Virus Type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392-3400, 1993
124. Groux H, Torpier G, Monte D, et al: Activationinduced death by apoptosis in CD4+ T cells from human immunodeficiency-infected asymptomatic individuals. J Exp Med 175:331-340, 1992
125. Meyaard L, Otto SA, Jonker RR, et al: Programmed death of T cells in HIV-1 infection. Science 257:217-219, 1992
126. Banda NK, Bemier J, Kurahara DK, et al: Crosslinking CD4 by Human Immunodeficiency Virus gp!20 primes T cells for activation-induced apoptosis. J Exp Med 176:10991106, 1992
127. Oyaizu N, Chirmule N, Malyanaramen VS, et al: Human immunodeficiency virus type 1 envelope protein gp!20 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sciences USA 87:2379-2383, 1990
128. Stewart SA, Poon B, Jowett JB, Chen IS: Human Immunodeficiency Virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol 71:5579-5592, 1997
129. Liu Y, Janeway CA: Interferon gamma plays a critical role in induced cell death of effector T cells: A possible third mechanism of self tolerance. J Exp Med 172:1735-1739, 1990
130. Clement M-V, Stamenkovic I: Fas and tumor necrosis factor receptor mediated cell death: Similarities and distinctions. J Exp Med 180:557-567, 1994.
131. Kornbluth RS: Significance of T cell apoptosis for macrophages in H1V infection. J Leuk Biol 56:247-256, 1994
132. Imberti L, Sottini A, Bettinardi A, et al: Selective depletion in HIV infection of T cells that bear specific T cell receptor Vbeta sequences. Science 254:860-862, 1991